JPMorgan analyst Richard Vosser raised the firm’s price target on Novo Nordisk to DKK 1,100 from DKK 925 and keeps an Overweight rating on the shares.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVO:
- Novo Nordisk added to Analyst Focus List at JPMorgan
- Novo Nordisk price target raised to $145 from $130 at Cowen
- Novo’s (NYSE:NVO) Wegovy is Boosting Stock Price by Reducing Weight
- Novo Nordisk price target raised to DKK 810 from DKK 780 at Berenberg
- Jim Simons’ Hedge Fund Renaissance Technologies is Buying These Stocks Now